Molecular TherapyPhysiologyPeer-reviewed journal article
Hepatic gene replacement restores energy metabolism and doubles the survival in mouse model of GRACILE syndrome, a neonatal mitochondrial disease
Rishi BanerjeeiD, Janne PurhoneniD, Nasrin SultanaiD, Oliver Ros, Anni I. NiemineniD, Christa KietziD, Vineta FellmaniD, Jukka KallijärviiD
Abstract
Preclinical gene therapy studies of mitochondrial diseases remain limited due to their multisystemic manifestations and the scarcity of physiologically relevant animal models. Mutations in BCS1L, a nuclear gene encoding an assembly factor for mitochondrial complex III (CIII), are the most common cause of pediatric CIII deficiency. The most severe phenotype, GRACILE syndrome, is caused by a homozygous Finnish founder mutation (c.A232G, p.S78G). The corresponding Bcs1lp.S78G knock-in mouse model effectively recapitulates the human disease, with juvenile-onset hepatopathy, tubulopathy, growth restriction, segmental progeria, and short survival. Here, we performed recombinant adeno-associated virus (rAAV)-mediated gene replacement in this model, which features a postnatal presymptomatic window until weaning. A single intraperitoneal injection of rAAV encoding wild-type Bcs1l restored CIII assembly and activity in the liver, preventing hepatopathy. Hepatocyte-specific correction was sufficient to ameliorate hypoglycemia, improve growth, normalize systemic metabolism, and extend survival by nearly two-fold, despite persistent CIII deficiency in other tissues. Remarkably, liver-directed rescue also prevented skeletal muscle transcriptomic changes, particularly those linked to altered energy substrate utilization. These results underscore the central role of the liver in systemic energy homeostasis and growth regulation in multiorgan mitochondrial diseases and demonstrate the therapeutic potential of hepatocyte-directed gene replacement in phenotypes with prominent hepatopathy. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=127 SRC="FIGDIR/small/677965v1_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@b1cf50org.highwire.dtl.DTLVardef@1a1c2e2org.highwire.dtl.DTLVardef@101bdb6org.highwire.dtl.DTLVardef@14e11e3_HPS_FORMAT_FIGEXP M_FIG Graphical abstract C_FIG
- organism: mouse
- assay: ATAC-seq
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 26th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Hepatic mitochondrial respiration is crucial for euthermia in complex III-deficient mice with impaired brown adipose tissue thermogenesis
Rishi Banerjee, Divya Upadhyay, … Jukka Kallijärvi·bioRxiv·Sep 23, 2024
- Gene replacement therapy provides benefit in an adult mouse model of Leigh syndrome
Robin Reynaud-Dulaurier, Giorgia Benegiamo, … Mickaël Decressac·BrainPeer-reviewed·Mar 18, 2020
- Rescue of lysosomal acid lipase deficiency in mice by rAAV8 liver gene transfer.
Marine Laurent, Rim Harb, … Mario Amendola·Communications MedicinePeer-reviewed·Apr 11, 2025
- A Genetic Model Therapy Proposes a Critical Role for Liver Dysfunction in Mitochondrial Biology and Disease
Ankit Sabharwal, Mark D. Wishman, … Stephen Carl Ekker·eLifePeer-reviewed·Nov 21, 2022
- Glycerol-3-phosphate activates ChREBP, FGF21 transcription and lipogenesis in Citrin Deficiency
Vinod Tiwari, Byungchang Jin, … Charles Brenner·Nature MetabolismPeer-reviewed·Nov 14, 2025
- MIC13-linked cristae disruption causes metabolic failure and early fibrotic remodelling in mitochondrial liver disease
Alexander Becker, Thomas Oliver Eichmann, … Ruchika Anand·Cell Death and DiseasePeer-reviewed·Sep 15, 2026